Surrogate end points for prostate cancer: what is prostate-specific antigen telling us?
D014408:Biomarkers, Tumor / Q000097:blood*; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000276:immunology* / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen